Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues

MLA

Olga Janoušková, et al. “Poly(2-Ethyl-2-Oxazoline) Conjugates with Doxorubicin for Cancer Therapy: In Vitro and in Vivo Evaluation and Direct Comparison to Poly[N-(2-Hydroxypropyl)Methacrylamide] Analogues.” Biomaterials, vol. 146, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....989fefdf71137aab3f568395fee10df5&authtype=sso&custid=ns315887.

APA

Olga Janoušková, Richard Hoogenboom, Marie Zadinova, Maarten Vergaelen, Martin Hruby, Bart Verbraeken, Ondrej Sedlacek, Jana Mattova, Bryn D. Monnery, Anita Höcherl, Jan Kučka, & Jiri Panek. (2017). Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues. Biomaterials, 146.

Chicago

Olga Janoušková, Richard Hoogenboom, Marie Zadinova, Maarten Vergaelen, Martin Hruby, Bart Verbraeken, Ondrej Sedlacek, et al. 2017. “Poly(2-Ethyl-2-Oxazoline) Conjugates with Doxorubicin for Cancer Therapy: In Vitro and in Vivo Evaluation and Direct Comparison to Poly[N-(2-Hydroxypropyl)Methacrylamide] Analogues.” Biomaterials 146 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....989fefdf71137aab3f568395fee10df5&authtype=sso&custid=ns315887.